Antihistamine leukotriene combinations
AssigneeAsta Medica Aktiengesellschaft
InventorsHildegard Poppe, Jurgen Engel, Istvan Szelenyi
Life of this patent
Estimating the term…
Loading patent…
AssigneeAsta Medica Aktiengesellschaft
InventorsHildegard Poppe, Jurgen Engel, Istvan Szelenyi
Estimating the term…
The invention relates to a pharmaceutical composition for the treatment of allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis, which comprises (a) a nonsedating antihistamine or a pharmaceutically acceptable salt thereof, (b) a leukotriene D4 antagonist, or a 5-lipoxygenase inhibitor, or a FLAP antagonist, or a pharmaceutically acceptable salt thereof, and (c) one or more of a conventional pharmaceutical vehicle, extender, and excipient, and to its use for manufacturing a composition for the treatment of allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis.
A pharmaceutical composition for the treatment of allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis, which comprises (a) a nonsedating antihistamine or a pharmaceutically acceptable salt thereof (b) a leukotriene D4 antagonist, or a 5-lipoxygenase inhibitor, or a FLAP antagonist, or a pharmaceutically acceptable salt thereof, and (c) one or more of a conventional pharmaceutical vehicle, extender, and excipient..
Use of a composition of (a) a nonsedating antihistamine or a pharmaceutically acceptable salt thereof, (b) a leukotriene D4 antagonist, or a 5-lipoxygenase inhibitor, or a FLAP antagonist, or a pharmaceutically acceptable salt thereof, for preparing a pharmaceutical composition or pharmaceutical agents, for the simultaneous or sequential treatment of allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis.
Dependencies are inferred from the claim text.